Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature
Background Anabolic androgenic steroids (AAS) usage is widespread and increasing. AAS drug-induced liver injury (DILI) is recognised but its clinical course and management is poorly described. We report 2 cases of AAS DILI with associated renal dysfunction, managed successfully with oral corticoster...
Saved in:
| Main Authors: | Mark R Thursz, Robin Daniel Abeles, Matthew Foxton, Shahid Khan, Robert Goldin, Belinda Smith, Suman Verma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000549.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Rare Case of Tirzepatide-Induced Hepatitis: Causality Assessment With the RUCAM Criteria
by: Rayan Tareg Ahmed, et al.
Published: (2025-01-01) -
The Burden of Anabolic Androgenic Steroid-Induced Gynecomastia
by: Meenu Beniwal, et al.
Published: (2023-08-01) -
Psychiatric complications of androgenic–anabolic steroid use in powerlifters
by: Shu-Fen Lin, et al.
Published: (2025-05-01) -
A Case of Delayed Hepatic Injury Associated with Teriflunomide Use as Assessed for Causality Using the Updated RUCAM
by: Riana Wurzburger
Published: (2022-01-01) -
Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAM
by: Roie Tzadok, et al.
Published: (2022-01-01)